Osteoboost Launched National Television Campaign
The medical wearable maker debuted its television advertisements in September 2026 to reach older adults.
Updated on Sept. 25, 2026 in Senior Health
Live Poll
Do you trust medical devices advertised directly on television as much as doctor-recommended treatments?
Osteoboost launched a national linear television advertising campaign in September 2026, targeting postmenopausal women over age 50. Following the campaign, the brand recorded its highest weekend sales total.
Why it matters
The company aims to address a market of 60 million Americans with osteopenia as recent interest in menopause and longevity drives demand for bone health solutions. The campaign highlights a gap in care, noting that only 10% of osteoporosis patients currently use pharmaceutical treatments.
The prescription device costs approximately $1,000 and requires 30 minutes of daily wear to reduce bone density loss. Additionally, 15% of buyers now secure their required prescriptions directly through the company website.
The players
Osteoboost
This company manufactures a prescription wearable device designed to treat osteopenia through targeted vibration therapy.
DirectAvenue
This agency manages media placement and advertising strategies for various brands, including national television campaigns.
The details
The television spots, placed by agency DirectAvenue, air during prime time and weekend daytime hours to reach the target demographic. The wearable device utilizes targeted vibrations on the spine and hips to mitigate bone density loss in patients.
Timeline
Osteoboost launched its national television campaign in September 2026.
The brand achieved its highest weekend sales total in September 2026.
Health Landscape
This marketing push reflects the broader industry shift toward direct-to-consumer health wearables that offer alternatives to traditional pharmaceutical regimens. It aligns with growing public focus on longevity and menopause-related health management.
Patients with osteopenia may find this device provides a non-pharmaceutical treatment option requiring 30 minutes of daily wear. Consumers can utilize telehealth services via the company website to obtain the necessary prescription for the device.
The takeaway
The rise of wearable medical devices indicates a growing consumer appetite for home-based therapies that complement or replace traditional medications. Patients should consult their physicians to determine if vibration-based therapy is appropriate for their specific bone health needs.
Further reading
Learn more about the latest innovations in Senior Health on our site.
More information
View product details and purchasing options on the Osteoboost product information and purchase site.
Source note: This article includes information reported by MediaPost.
Live Poll
Do you trust medical devices advertised directly on television as much as doctor-recommended treatments?
